European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - cefovecin (as sodium salt) - antibacterials for systemic use - dogs; cats - dogsfor the treatment of skin and soft-tissue infections including pyoderma, wounds and abscesses associated with staphylococcus pseudintermedius, β-haemolytic streptococci, escherichia coli and / or pasteurella multocida.for the treatment of urinary-tract infections associated with escherichia coli and / or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy in the treatment of severe infections of the gingiva and periodontal tissues associated with porphyromonas spp. and prevotella spp.catsfor the treatment of skin and soft-tissue abscesses and wounds associated with pasteurella multocida, usobacterium spp., bacteroides spp., prevotella oralis, β-haemolytic streptococci and / or staphylococcus pseudintermedius.for the treatment of urinary-tract infections associated with escherichia coli.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

zoetis belgium s.a., belgium - cefovecin - powder for injection - 851.98 mg/ml

Israel - English - Ministry of Health

zoetis israel holding b.v., israel - cefovicin as sodium salt - powder and solvent for solution for injection - cefovicin as sodium salt 80 mg/dose - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp. cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.